NV5 Global Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $83.84 million. The enterprise value is $94.49 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 37.82 million shares outstanding. The number of shares has increased by 11.37% in one year.
| Current Share Class | 37.82M |
| Shares Outstanding | 37.82M |
| Shares Change (YoY) | +11.37% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 14.55% |
| Owned by Institutions (%) | 24.46% |
| Float | 25.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.86 |
| Forward PS | 1.64 |
| PB Ratio | 11.67 |
| P/TBV Ratio | 11.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.72, with a Debt / Equity ratio of 5.24.
| Current Ratio | 4.72 |
| Quick Ratio | 3.84 |
| Debt / Equity | 5.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.10 |
Financial Efficiency
Return on equity (ROE) is -154.54% and return on invested capital (ROIC) is -15.36%.
| Return on Equity (ROE) | -154.54% |
| Return on Assets (ROA) | -12.45% |
| Return on Invested Capital (ROIC) | -15.36% |
| Return on Capital Employed (ROCE) | -25.85% |
| Revenue Per Employee | $211,418 |
| Profits Per Employee | -$78,450 |
| Employee Count | 220 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 2.04 |
Taxes
In the past 12 months, Apyx Medical has paid $247,000 in taxes.
| Income Tax | 247,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +117.79% in the last 52 weeks. The beta is 1.39, so Apyx Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | +117.79% |
| 50-Day Moving Average | 2.04 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 55.57 |
| Average Volume (20 Days) | 103,888 |
Short Selling Information
The latest short interest is 319,516, so 0.84% of the outstanding shares have been sold short.
| Short Interest | 319,516 |
| Short Previous Month | 299,211 |
| Short % of Shares Out | 0.84% |
| Short % of Float | 1.25% |
| Short Ratio (days to cover) | 2.85 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $46.51 million and -$17.26 million in losses. Loss per share was -$0.45.
| Revenue | 46.51M |
| Gross Profit | 28.67M |
| Operating Income | -12.31M |
| Pretax Income | -28.50M |
| Net Income | -17.26M |
| EBITDA | -11.75M |
| EBIT | -12.31M |
| Loss Per Share | -$0.45 |
Full Income StatementBalance Sheet
The company has $29.30 million in cash and $39.08 million in debt, giving a net cash position of -$9.78 million or -$0.26 per share.
| Cash & Cash Equivalents | 29.30M |
| Total Debt | 39.08M |
| Net Cash | -9.78M |
| Net Cash Per Share | -$0.26 |
| Equity (Book Value) | 7.46M |
| Book Value Per Share | 0.19 |
| Working Capital | 39.35M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.31 million and capital expenditures -$718,000, giving a free cash flow of -$10.03 million.
| Operating Cash Flow | -9.31M |
| Capital Expenditures | -718,000 |
| Free Cash Flow | -10.03M |
| FCF Per Share | -$0.27 |
Full Cash Flow StatementMargins
Gross margin is 61.63%, with operating and profit margins of -26.46% and -37.11%.
| Gross Margin | 61.63% |
| Operating Margin | -26.46% |
| Pretax Margin | -36.65% |
| Profit Margin | -37.11% |
| EBITDA Margin | -25.27% |
| EBIT Margin | -26.46% |
| FCF Margin | n/a |
Dividends & Yields
Apyx Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.37% |
| Shareholder Yield | -11.37% |
| Earnings Yield | -20.37% |
| FCF Yield | -11.84% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 41.47% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 6, 1994. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jan 6, 1994 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
Apyx Medical has an Altman Z-Score of -0.56 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.56 |
| Piotroski F-Score | 1 |
